In order to give you a better service Airbus uses cookies. By continuing to browse the site you are agreeing to our use of cookies I agree

generic imagery for corporate topics, crisis communications, etc.

Coronavirus 

Airbus is closely monitoring the evolution of the Coronavirus (COVID-19) pandemic across the globe and is assessing the situation, the impact on employees, customers, suppliers and the business.

The health and safety of Airbus employees is paramount.

Airbus is following WHO and local health authority guidance. In addition Airbus has updated its workplace safety and travel recommendations to employees, customers and to visitors, according to the latest developments.

 

Workplace safety at Airbus sites globally

Rules are being implemented on day to day behaviours relating to hygiene, social interaction and physical distancing, ill health reporting and travel to and from Airbus’ global sites.

Airbus is following national guidelines with a pause on all but essential production activities in Spain until April 9th and Canada until April 13th.  Activities in the UK and German wing plants have also been reduced over an extended three week Easter break.

Activities at Airbus’ sites in France and Spain were temporarily paused for four days on March 17th, to implement stringent health and safety processes respecting hygiene, cleaning and self-distancing. These stringent measures, standards and processes have been implemented at all Airbus sites worldwide.

Airbus is doing its utmost to support employees who are affected by school and child care closures by providing maximum work flexibility. This includes enabling employees to work from home where possible and at the same time ensuring business continuity in order to meet customer commitments while ensuring the health and safety of all employees and compliance with national regulations.   

Anyone with COVID-19 symptoms must declare, seek medical advice and self quarantine. Airbus is keeping all employees updated on the latest developments and recommendations.

 

Travel directives

Airbus employees are advised to restrict travel to business critical missions only excluding to high risk regions.

Visits to Airbus from high risk regions are halted.

Employees having returned from any high risk regions must self-quarantine for 14 days.

Staff, customers and visitors must self declare their travel history

 

Business impact

On March 23rd, Airbus disclosed additional measures to support employees, customers and to safeguard business continuity. The 2020 guidance was withdrawn. Airbus maintains a strong focus on backlog management, supporting customers and securing business continuity through these unprecedented times.

We remain in close contact with our customers and suppliers and are working together to minimise the impact on their operations.

Guillaume Faury Airbus CEO video statement: click here

 

Impact on the Annual General Meeting 2020

Airbus has convened its 2020 Annual General Meeting in Amsterdam on 16 April. Due to the global outbreak of COVID-19, Airbus discourages physical attendance and strongly encourages shareholders to vote by proxy in line with public health and safety measures.

 

Airbus joins initiatives against COVID-19

Airbus is deploying aircraft to supply additional face mask supplies from China to support the health systems in France, Germany, Spain and the United Kingdom. Airbus engineers and technology teams have also been mobilised for the Ventilator Challenge UK consortium to accelerate production of two existing medical ventilator designs using Airbus’ industrial skills and facilities.

Latest related press releases and news

“Our sole objective is to make a difference”

Airbus’ Aeolus satellite supports weather forecasting amid COVID-19

en

Airbus military aircraft perform life-saving medevac missions during the COVID-19 pandemic

Christoph Zammert: How Airbus is helping frontline helicopter operators in the fight against COVID-19

Airbus unites in the global fight against coronavirus

Airbus and Koniku Inc. embark on disruptive biotechnology solutions for aviation security operations

en
Back to top